Evidence map›Paper›PMID 41665182›Full record

ArticleGut microbes2026

Shin Fujiwara, Jonguk Park, Mariko Takeda, Takumi Miyatake, Yoshie Saito, Seiya Makino, Yun-Gi Kim

Abstract read
In one paragraph

Article in Gut microbes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shin FujiwaraWellness Science Labs, Meiji Holdings Co., Ltd., Tokyo, Japan.ORCID 0009-0000-6028-4744
Jonguk ParkWellness Science Labs, Meiji Holdings Co., Ltd., Tokyo, Japan.ORCID 0000-0003-4872-385X
Mariko TakedaWellness Science Labs, Meiji Holdings Co., Ltd., Tokyo, Japan.
Takumi MiyatakeWellness Science Labs, Meiji Holdings Co., Ltd., Tokyo, Japan.
Yoshie SaitoWellness Science Labs, Meiji Holdings Co., Ltd., Tokyo, Japan.
Seiya MakinoR&D Division, Meiji Co., Ltd., Tokyo, Japan.
Yun-Gi KimWellness Science Labs, Meiji Holdings Co., Ltd., Tokyo, Japan.ORCID 0000-0003-4251-1848

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is frequently accompanied by inflammaging-a chronic, low-grade inflammatory state that contributes to functional decline and disease risk. Disruption of the intestinal barrier is increasingly being recognized as a key driver of inflammaging; however, its relationship with the gut microbiota in older adults remains poorly understood. Here, we demonstrate a significant association of intestinal barrier dysfunction markers with systemic inflammatory markers using a cross-sectional study in this population. Notably, the genus

Indexed as

Gastrointestinal MicrobiomeIntestinal MucosaN-Acetylneuraminic AcidAgedAgingCross-Sectional StudiesFecesFemaleHumansInflammationIntestinal Barrier FunctionMaleMucinsMucinsN-Acetylneuraminic AcidInflammagingintestinal barriermicrobiotamucinParabacteroidessialic acid

Identifiers

PMID41665182
PMCPMC12893687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.